Audenz (National Stockpile) (influenza A (H5N1) vaccine mvs (6mos up)/adjuvant MF59C.1/PF)
Influenza Vaccine Intramuscular Syringe (Ml); Intramuscular Vial (Ml)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Generic name: influenza A (H5N1) vaccine mvs (6mos up)/adjuvant MF59C.1/PF
Drug class: Influenza Vaccine
Therapeutic class: Biologicals
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Audenz (National Stockpile)
Indications
The following indications are listed for Audenz (National Stockpile):
- Avian Influenza (H5n1) Vaccination
Also known as: Active Immunization Against Avian Influenza A H5n1 Virus, Avian Influenza A H5n1 Virus Infection Prevention.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Audenz Syringe (Stockpile) | Maintenance | Inject 0.5 milliliter (7.5 mcg) by intramuscular route once. |
| Audenz 5 Ml Vial (Stockpile) | Maintenance | Inject 0.5 milliliter (7.5 mcg) by intramuscular route once. |
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient.
Vaccines/Pariglasgene Brecaparvovec
SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient.
MECHANISM OF ACTION: Pariglasgene brecaparvovec therapy may decrease the effectiveness of vaccines. The mechanism is not known.(1)
CLINICAL EFFECTS: The expected serum antibody response may not be obtained.(1)
PREDISPOSING FACTORS: None determined.
PATIENT MANAGEMENT: The US manufacturer of pariglasgene brecaparvovec states that vaccines should be avoided for 1 month prior to pariglasgene brecaparvovec administration.(1)
DISCUSSION: Pariglasgene brecaparvovec therapy may decrease the effectiveness of vaccines.(1)
There are no severe interactions for this drug.
Moderate Interaction: Assess the risk to the patient and take action as needed.
Vaccines/Hepatitis B Vaccine (Fendrix)
SEVERITY LEVEL: 3-Moderate Interaction: Assess the risk to the patient and take action as needed.
MECHANISM OF ACTION: No data is available on the concurrent administration of the hepatitis B vaccine Fendrix and other vaccines.(1)
CLINICAL EFFECTS: It is unknown if concurrent administration of the hepatitis B vaccine Fendrix and other vaccines will affect the efficacy of either vaccine.(1)
PREDISPOSING FACTORS: None determined.
PATIENT MANAGEMENT: The Swedish manufacturer of Fendrix states that since there is no data available for the concurrent administration of Fendrix with other vaccines, the administration of Fendrix and other vaccines should be separated by 2 to 3 weeks.(1)
DISCUSSION: No data is available on the concurrent administration of the hepatitis B vaccine Fendrix with other vaccines.(1)
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
- Guillain-barre syndrome
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
Rare or Very Rare
- Anaphylaxis
- Angioedema
- Bell's palsy
- Brachial plexus disorder
- Cellulitis
- Dyspnea
- Encephalopathy
- Guillain-barre syndrome
- Hypersensitivity drug reaction
- Myelitis
- Optic neuritis
- Serum sickness
- Stevens-johnson syndrome
- Thrombocytopenic disorder
- Vasculitis
More Frequent
- Bruising
- Chills
- Erythema
- Fatigue
- Headache disorder
- Induration of skin
- Injection site pain
- Injection site sequelae
- Malaise
- Myalgia
- Pruritus of skin
Less Frequent
- Appetite changes
- Arthralgia
- Cough
- Diarrhea
- Ecchymosis
- Fever
- Injection site erythema
- Injection site inflammation
- Nausea
- Pharyngitis
- Vomiting
Rare or Very Rare
- Back pain
- Dizziness
- Extensive limb swelling after injection
- Flushing
- Lymphadenopathy
- Neuralgia
- Pain in oropharynx
- Paresthesia
- Seizure disorder
- Skin rash
- Syncope
- Urticaria
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Avian influenza (h5n1) vaccination | ||
| Z23 | ICD10CM | Encounter for immunization |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.